Press release
Polymerase Chain Reaction (PCR) Market to Reach USD 24.0 Billion by 2035, Driven by Rising Demand for Molecular Diagnostics and Genetic Testing
Polymerase Chain Reaction (PCR) Market
👉 Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=830
Market Overview
Polymerase chain reaction (abbreviated PCR) is a laboratory technique for speedy production (amplification) of millions to billions of copies of a specific segment of DNA, which can then be studied in detail. PCR involves using short synthetic DNA fragments called primers to select a segment of the genome to be amplified, and then multiple rounds of DNA synthesis to amplify that segment.
Analysts' Viewpoint
Increase in PCR's usage has allowed it to be a key part of the ongoing expansion of molecular diagnostics and biomedical research. The use of PCR for the identification of nucleic acids with a high level of specificity has made it a vital part of the testing for infectious diseases, genetic analysis of diseases, the study of cancer, and for the development of new treatments based on the characteristics of individual patients. The dependability and versatility of this technology have led to a continued and increasing demand for its use in clinical laboratories, the other research institutions, and in the biotechnology sector.
In addition, the growth of the PCR market has also been supported by more advanced technologies now available in the market. Examples of advancements in PCR technology are real-time PCR, digital PCR, automation, and the use of high-throughput methods for the production of PCR products.
These new technologies offer improvements in the sensitivity, speed, and efficiency of PCR procedures. This, along with the increased capability of PCR to support such a wide variety of applications (pathogen detection; research into gene expression), continues to reinforce the use of PCR in modern laboratories.
Analysis of Key Players
The competitive landscape is characterized by technological innovation, product launches, strategic partnerships, and investments in advanced molecular diagnostic solutions.
Leading companies operating in the global polymerase chain reaction (PCR) market include:
• Abbott
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• BioMérieux
• DiaSorin S.p.A.
• Meridian Bioscience, Inc.
• QIAGEN
• QuidelOrtho Corporation
• Siemens Healthineers AG
• Becton, Dickinson and Company (BD)
• Bruker
• Cosmos Biomedical Ltd.
• Agilent Technologies, Inc.
• PCR Biosystems Inc.
• Quantabio
• Promega Corporation
• Other Prominent Players
Strategic investments in automated PCR systems, advanced reagents, digital PCR technologies, and molecular diagnostic platforms remain key competitive strategies among market participants.
Recent Developments (2024-2025)
• In July 2025, Bio-Rad Laboratories, Inc. announced the launch of four new Droplet Digital PCR (ddPCR) platforms. The newly introduced instruments include Bio-Rad's QX Continuum ddPCR system along with the QX700 series of ddPCR platforms acquired as part of the company's recently completed acquisition of digital PCR developer Stilla Technologies
• In April 2025, Seegene Inc. started advancing its vision for innovation in laboratory automation with the development of CURECA a next-generation system currently under development, designed to streamline automation in polymerase chain reaction (PCR) testing and laboratory environments. The company announced that it will showcase a conceptual video introducing the CURECA system at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global 2025), held April 11-15 in Vienna, Austria
• In January 2025, QIAGEN announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analyzed from a single biological sample. The new capabilities overcome the assay design challenges of currently available quantitative multiplex PCR methods, making QIAcuity digital PCR ideal for applications such as translational research, microbiome analysis, pathogen detection and the development of cell and gene therapies
👉 Discuss Implications for Your Industry Request Sample Market Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=830
Key Developments & Trends
• Molecular Diagnostics Growth: Increasing use of PCR for disease detection and clinical testing.
• Digital PCR Adoption: Rising demand for highly sensitive and precise genetic analysis.
• Point-of-Care Testing Expansion: Growing availability of rapid PCR-based diagnostic solutions.
• Genomics Research Growth: Increasing applications in genetic sequencing and biotechnology.
• Automation Integration: Development of automated PCR workflows for improved efficiency.
Challenges
• High Equipment Costs: Advanced PCR systems require significant initial investment.
• Technical Expertise Requirements: Skilled professionals are needed for operation and interpretation.
• Regulatory Requirements: Strict approval processes for diagnostic applications.
• Competition from Alternative Technologies: Emerging molecular diagnostic methods may impact adoption.
Opportunities
• Personalized Medicine Expansion: Increasing use of PCR in targeted therapies and genetic profiling.
• Infectious Disease Monitoring: Growing demand for rapid pathogen detection.
• Biotechnology Research Growth: Rising investments in life sciences research.
• Emerging Market Adoption: Expanding healthcare infrastructure and diagnostic capabilities.
Market Segmentation
By Product Type
• Instruments
• Reagent and Consumables
• Software and Services
By Technique
• Conventional PCR
• Real-Time PCR
• Reverse Transcriptase PCR
• Digital PCR
• Others (Multiplex PCR)
By Application
• Clinical
o Pathogen Testing
o Oncology Testing
o Blood Screening
o Others
• Research
• Others
By End-user
• Hospitals and Clinics
• Biotechnology and Pharmaceutical Companies
• Diagnostic Centers
• Others (Academic and Research Organization, etc.)
Conclusion
The polymerase chain reaction (PCR) market is expected to witness sustained growth as molecular diagnostics, genomics research, and personalized medicine continue to expand globally. Through 2035, advancements in real-time PCR, digital PCR, automation, and point-of-care testing are expected to accelerate market growth. As demand for accurate and rapid genetic analysis increases, PCR technology will remain a fundamental tool in healthcare, biotechnology, and life science research.
👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=830<ype=S
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Polymerase Chain Reaction (PCR) Market to Reach USD 24.0 Billion by 2035, Driven by Rising Demand for Molecular Diagnostics and Genetic Testing here
News-ID: 4573980 • Views: …
More Releases from Transparency Market Research
Medical Simulation Market to Surpass US$ 13.1 Billion by 2034, Driven by Growing …
The global medical simulation market was valued at US$ 2.6 billion in 2023 and is projected to reach more than US$ 13.1 billion by 2034, expanding at a CAGR of 16.4% from 2024 to 2034. The market growth is driven by increasing demand for advanced healthcare training solutions, rising adoption of simulation-based medical education, growing emphasis on patient safety, and technological advancements in virtual reality (VR), augmented reality (AR), and…
Tactile Sensor Market to Reach US$ 65.6 Billion by 2035, Driven by Rising Adopti …
The global tactile sensor market was valued at US$ 16.2 billion in 2024 and is projected to reach US$ 65.6 billion by 2035, growing at a CAGR of 13.4% from 2025 to 2035. The market growth is driven by increasing adoption of robotics, rising demand for human-machine interaction technologies, advancements in wearable devices, and growing integration of touch-sensitive systems across automotive, healthcare, consumer electronics, and industrial applications.
👉 Get sample market…
GLP-1 Analogues Market to Reach USD 211.8 Billion by 2035, Driven by Rising Dema …
The global GLP-1 analogues market was valued at USD 51.6 billion in 2024 and is projected to reach USD 211.8 billion by 2035, growing at a CAGR of 13.7% from 2025 to 2035. The market growth is driven by the rising prevalence of diabetes and obesity, increasing demand for effective metabolic disorder treatments, advancements in incretin-based therapies, and growing adoption of GLP-1 receptor agonists for improved patient outcomes.
👉 Get sample…
Flow Chemistry Market to Reach US$ 5.9 Billion by 2035, Driven by Rising Adoptio …
The global flow chemistry market was valued at USD 2.1 billion in 2024 and is projected to reach USD 5.9 billion by 2035, growing at a CAGR of 9.7% from 2025 to 2035. The market growth is driven by increasing demand for efficient chemical synthesis processes, rising adoption of continuous manufacturing technologies, growing pharmaceutical research activities, and the need for safer, scalable, and sustainable chemical production methods.
👉 Get sample market…
More Releases for PCR
Emerging Trends to Reshape the Global Real-Time PCR, Digital PCR And End-Point P …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Real-Time PCR, Digital PCR And End-Point PCR Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market encompassing real-time PCR, digital PCR, and end-point PCR has experienced robust expansion over the past few years, projecting a rise from $38.37 billion in 2024 to $41.55 billion…
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
The PCR And Realtime PCR Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current PCR And Realtime PCR Testing Market Size and Its Estimated Growth Rate?
The PCR and real-time PCR testing market has grown strongly, rising from $10.55 billion in 2024…
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size?
There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is…
Role Of Real-Time Rt-Pcr In Accelerating Covid-19 Diagnosis And Driving Pcr And …
How Will the PCR And Realtime PCR Testing Market Grow, and What Is the Projected Market Size?
There has been a significant growth in the market size of PCR and realtime PCR testing in the last few years. Its size is expected to increase from $10.55 billion in 2024 to $11.21 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.3%. The growth observed in the historic period is…
Q-PCR and D-PCR Devices Market: Revolutionizing Molecular Diagnostics
The Q-PCR and D-PCR devices market has experienced significant growth in recent years, driven by advancements in molecular biology and the increasing demand for accurate and sensitive diagnostic tools. These technologies have revolutionized the field of molecular diagnostics, enabling researchers and clinicians to detect and quantify specific DNA or RNA sequences with high precision.
Market Size and Growth
The global Q-PCR and D-PCR devices market is estimated to be worth billions of…
Real-Time PCR, Digital PCR And End-Point PCR Global Market Analysis, Trends, Gro …
The new report published by The Business Research Company, titled "Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the real-time pcr, digital pcr and end-point pcr market size has grown strongly…
